Skip to main content
. 2017 Mar 3;8(17):28042–28051. doi: 10.18632/oncotarget.15886

Figure 4. The expression of LC3-I, LC3-II, PTEN, p-AKT, pmTOR and beclin1.

Figure 4

1-1,1-2: Ishikawa cells; 2-1, 2-2: Ishikawa-PR cells; 3-1, 3-2: Ishikawa cells with miR-205 inhibitor; 4-1, 4-2: Ishikawa-PR cells with miR-205 inhibitor